April 23, 2014 — Manhattan Diagnostic Radiology (MDR), a wholly owned subsidiary of RadNet Inc., announced that 3-D mammography breast cancer screening is now available at its 66th Street location.

MDR is the first freestanding, full-service radiology provider in Manhattan to offer this 3-D technology. Also known as breast tomosynthesis, this newest software makes 2-D images from a 3D scan, an upgrade only recently approved for use by the U.S. Food and Drug Administration (FDA). Three-dimensional mammography will eventually allow for faster scan times and reduced radiation exposure.

Standard 2-D mammograms take two images of each breast, one horizontal and one vertical. With 3-D mammography, the X-ray machine swings in an arc, acquiring approximately 60 individual millimeter-thin section images. The radiologist then views these images on a high-resolution computer monitor.

"This new way of performing mammograms improves our ability to find cancers, particularly in women with dense breast tissue in whom a small malignancy can be difficult to detect. Already in our early experience with this technology, we have discovered unsuspected cancers, which I am convinced would not have been detected with 2-D mammography alone. Three-dimensional mammography also reduces the number of false positive findings, which cuts back on additional testing and reduces anxiety," said Melissa Scheer, M.D., breast-imaging specialist at MDR.

Since insurance does not yet cover the cost of 3-D mammography, there will be a charge for the procedure at MDR.

For more information: www.radnet.com


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
Subscribe Now